<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>T2D Clinical Compass - Rapid Reference Tool</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --red-bg: #FEF2F2;
            --red-border: #DC2626;
            --red-text: #991B1B;
            --green-bg: #F0FDF4;
            --green-border: #16A34A;
            --green-text: #166534;
            --blue-bg: #EFF6FF;
            --blue-border: #2563EB;
            --blue-text: #1E40AF;
            --neutral-bg: #F8FAFC;
            --neutral-border: #94A3B8;
            --text-primary: #1E293B;
            --text-secondary: #64748B;
            --shadow-sm: 0 1px 2px rgba(0, 0, 0, 0.05);
            --shadow-md: 0 4px 6px -1px rgba(0, 0, 0, 0.1);
            --shadow-lg: 0 10px 15px -3px rgba(0, 0, 0, 0.1);
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            background: #F1F5F9;
            color: var(--text-primary);
            line-height: 1.6;
        }

        /* Emergency Banner */
        .emergency-banner {
            background: linear-gradient(135deg, var(--red-border), #B91C1C);
            color: white;
            padding: 1rem 2rem;
            position: sticky;
            top: 0;
            z-index: 1000;
            display: flex;
            align-items: center;
            gap: 1rem;
            box-shadow: var(--shadow-lg);
            animation: pulse-red 2s infinite;
        }

        @keyframes pulse-red {
            0%, 100% { box-shadow: 0 0 0 0 rgba(220, 38, 38, 0.4); }
            50% { box-shadow: 0 0 0 10px rgba(220, 38, 38, 0); }
        }

        .emergency-banner svg {
            width: 28px;
            height: 28px;
            flex-shrink: 0;
        }

        .emergency-banner h1 {
            font-size: 1.25rem;
            font-weight: 700;
        }

        .emergency-banner p {
            font-size: 0.9rem;
            opacity: 0.95;
        }

        /* Navigation Sidebar */
        .nav-sidebar {
            position: fixed;
            left: 0;
            top: 70px;
            bottom: 0;
            width: 240px;
            background: white;
            border-right: 1px solid #E2E8F0;
            padding: 1.5rem 0;
            overflow-y: auto;
            z-index: 100;
        }

        .nav-sidebar h3 {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-secondary);
            padding: 0 1.5rem;
            margin-bottom: 0.75rem;
        }

        .nav-link {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 0.75rem 1.5rem;
            color: var(--text-primary);
            text-decoration: none;
            font-size: 0.9rem;
            transition: all 0.2s ease;
            border-left: 3px solid transparent;
        }

        .nav-link:hover {
            background: var(--neutral-bg);
            border-left-color: var(--blue-border);
        }

        .nav-link svg {
            width: 18px;
            height: 18px;
            flex-shrink: 0;
        }

        /* Main Content */
        .main-content {
            margin-left: 240px;
            padding: 2rem;
            max-width: 1400px;
        }

        /* Section Styling */
        .section {
            margin-bottom: 3rem;
            scroll-margin-top: 100px;
        }

        .section-header {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            margin-bottom: 1.5rem;
            padding-bottom: 0.75rem;
            border-bottom: 2px solid #E2E8F0;
        }

        .section-header svg {
            width: 24px;
            height: 24px;
            color: var(--blue-border);
        }

        .section-header h2 {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--text-primary);
        }

        /* Red Flag Cards */
        .red-flag-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 1.5rem;
        }

        .red-flag-card {
            background: var(--red-bg);
            border: 2px solid var(--red-border);
            border-radius: 12px;
            padding: 1.5rem;
            transition: all 0.3s ease;
        }

        .red-flag-card:hover {
            transform: translateY(-2px);
            box-shadow: var(--shadow-md);
        }

        .red-flag-card h3 {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--red-text);
            font-size: 1.1rem;
            font-weight: 700;
            margin-bottom: 1rem;
        }

        .red-flag-card h3 svg {
            width: 20px;
            height: 20px;
        }

        .red-flag-card ul {
            list-style: none;
        }

        .red-flag-card li {
            padding: 0.5rem 0;
            border-bottom: 1px solid rgba(220, 38, 38, 0.2);
            font-size: 0.9rem;
        }

        .red-flag-card li:last-child {
            border-bottom: none;
        }

        .red-flag-card li::before {
            content: "⚠ ";
            margin-right: 0.5rem;
        }

        /* Action Required Badge */
        .action-badge {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.5rem 1rem;
            border-radius: 50px;
            font-size: 0.85rem;
            font-weight: 600;
            margin-bottom: 1rem;
        }

        .action-badge.emergency {
            background: var(--red-border);
            color: white;
        }

        .action-badge.urgent {
            background: #F59E0B;
            color: white;
        }

        .action-badge.standard {
            background: var(--blue-border);
            color: white;
        }

        /* Two Column Layout */
        .two-column {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 2rem;
        }

        @media (max-width: 900px) {
            .two-column {
                grid-template-columns: 1fr;
            }
        }

        /* Drug Cards */
        .drug-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(380px, 1fr));
            gap: 1.5rem;
        }

        .drug-card {
            background: white;
            border-radius: 12px;
            box-shadow: var(--shadow-md);
            overflow: hidden;
            transition: all 0.3s ease;
        }

        .drug-card:hover {
            transform: translateY(-4px);
            box-shadow: var(--shadow-lg);
        }

        .drug-card-header {
            padding: 1.25rem 1.5rem;
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
        }

        .drug-card-header.blue {
            background: linear-gradient(135deg, var(--blue-border), #1D4ED8);
            color: white;
        }

        .drug-card-header.green {
            background: linear-gradient(135deg, var(--green-border), #15803D);
            color: white;
        }

        .drug-card-header.red {
            background: linear-gradient(135deg, var(--red-border), #B91C1C);
            color: white;
        }

        .drug-card-header.amber {
            background: linear-gradient(135deg, #D97706, #B45309);
            color: white;
        }

        .drug-name {
            font-size: 1.25rem;
            font-weight: 700;
        }

        .drug-examples {
            font-size: 0.85rem;
            opacity: 0.9;
            margin-top: 0.25rem;
        }

        .drug-tag {
            padding: 0.35rem 0.75rem;
            border-radius: 50px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
        }

        .tag-first-line {
            background: rgba(255, 255, 255, 0.25);
            border: 1px solid white;
        }

        .tag-cv-benefit {
            background: var(--green-bg);
            color: var(--green-text);
            border: 1px solid var(--green-border);
        }

        .tag-hypo-risk {
            background: var(--red-bg);
            color: var(--red-text);
            border: 1px solid var(--red-border);
        }

        .drug-card-body {
            padding: 1.5rem;
        }

        .drug-info-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 1rem;
        }

        .info-box {
            padding: 1rem;
            border-radius: 8px;
            font-size: 0.85rem;
        }

        .info-box.benefits {
            background: var(--green-bg);
            border: 1px solid var(--green-border);
        }

        .info-box.risks {
            background: var(--red-bg);
            border: 1px solid var(--red-border);
        }

        .info-box.general {
            background: var(--neutral-bg);
            border: 1px solid var(--neutral-border);
        }

        .info-box h4 {
            font-size: 0.8rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            margin-bottom: 0.75rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .info-box h4 svg {
            width: 16px;
            height: 16px;
        }

        .benefits h4 { color: var(--green-text); }
        .risks h4 { color: var(--red-text); }
        .general h4 { color: var(--text-secondary); }

        .info-box ul {
            list-style: none;
        }

        .info-box li {
            padding: 0.4rem 0;
            padding-left: 1.25rem;
            position: relative;
        }

        .benefits li::before {
            content: "✓";
            position: absolute;
            left: 0;
            color: var(--green-border);
            font-weight: bold;
        }

        .risks li::before {
            content: "✗";
            position: absolute;
            left: 0;
            color: var(--red-border);
            font-weight: bold;
        }

        .general li::before {
            content: "•";
            position: absolute;
            left: 0;
            color: var(--text-secondary);
        }

        /* Comparison Table */
        .table-container {
            background: white;
            border-radius: 12px;
            box-shadow: var(--shadow-md);
            overflow: hidden;
        }

        .comparison-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 0.85rem;
        }

        .comparison-table thead {
            background: var(--neutral-bg);
        }

        .comparison-table th {
            padding: 1rem;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid var(--neutral-border);
        }

        .comparison-table td {
            padding: 0.75rem 1rem;
            border-bottom: 1px solid #E2E8F0;
        }

        .comparison-table tbody tr {
            transition: background 0.2s ease;
        }

        .comparison-table tbody tr:hover {
            background: var(--neutral-bg);
        }

        .check {
            color: var(--green-border);
            font-weight: bold;
        }

        .cross {
            color: var(--red-border);
            font-weight: bold;
        }

        .neutral {
            color: var(--text-secondary);
        }

        .cell-highlight-green {
            background: var(--green-bg) !important;
        }

        .cell-highlight-red {
            background: var(--red-bg) !important;
        }

        /* NICE Algorithm Box */
        .nice-box {
            background: linear-gradient(135deg, var(--blue-bg), #DBEAFE);
            border: 2px solid var(--blue-border);
            border-radius: 12px;
            padding: 2rem;
            margin-bottom: 2rem;
        }

        .nice-box h3 {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            color: var(--blue-text);
            font-size: 1.25rem;
            margin-bottom: 1.5rem;
        }

        .nice-box h3 svg {
            width: 28px;
            height: 28px;
        }

        .algorithm-step {
            display: flex;
            align-items: center;
            gap: 1rem;
            margin-bottom: 1rem;
            flex-wrap: wrap;
        }

        .step-box {
            padding: 0.75rem 1.25rem;
            border-radius: 8px;
            font-weight: 600;
            font-size: 0.9rem;
        }

        .step-box.metformin {
            background: var(--blue-border);
            color: white;
        }

        .step-box.gliflozin {
            background: var(--green-border);
            color: white;
        }

        .step-box.decision {
            background: white;
            border: 2px solid var(--blue-border);
            color: var(--blue-text);
        }

        .arrow {
            color: var(--text-secondary);
            font-size: 1.5rem;
        }

        /* Accordion */
        .accordion {
            margin-top: 1rem;
        }

        .accordion-item {
            background: white;
            border: 1px solid #E2E8F0;
            border-radius: 8px;
            margin-bottom: 0.75rem;
            overflow: hidden;
        }

        .accordion-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 1rem 1.25rem;
            cursor: pointer;
            background: white;
            transition: background 0.2s ease;
        }

        .accordion-header:hover {
            background: var(--neutral-bg);
        }

        .accordion-header h4 {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            font-size: 1rem;
            font-weight: 600;
        }

        .accordion-header h4 svg {
            width: 20px;
            height: 20px;
            color: var(--blue-border);
        }

        .accordion-icon {
            width: 24px;
            height: 24px;
            transition: transform 0.3s ease;
        }

        .accordion-item.active .accordion-icon {
            transform: rotate(180deg);
        }

        .accordion-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.3s ease;
        }

        .accordion-content-inner {
            padding: 0 1.25rem 1.25rem;
        }

        .accordion-item.active .accordion-content {
            max-height: 500px;
        }

        /* DVLA Table */
        .dvla-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 1.5rem;
        }

        @media (max-width: 1000px) {
            .dvla-grid {
                grid-template-columns: 1fr;
            }
        }

        .dvla-card {
            background: white;
            border-radius: 12px;
            box-shadow: var(--shadow-md);
            overflow: hidden;
        }

        .dvla-card-header {
            padding: 1rem 1.5rem;
            font-weight: 700;
            font-size: 1.1rem;
            color: white;
        }

        .dvla-card-header.group1 {
            background: var(--green-border);
        }

        .dvla-card-header.group2 {
            background: var(--red-border);
        }

        .dvla-card-header.sulphonylurea {
            background: #F59E0B;
        }

        .dvla-card-body {
            padding: 1.5rem;
        }

        .dvla-item {
            display: flex;
            align-items: flex-start;
            gap: 0.75rem;
            padding: 0.5rem 0;
            font-size: 0.9rem;
        }

        .dvla-item svg {
            width: 18px;
            height: 18px;
            flex-shrink: 0;
            margin-top: 2px;
        }

        .dvla-item.green svg { color: var(--green-border); }
        .dvla-item.red svg { color: var(--red-border); }

        /* Sick Day Rules */
        .sick-day-box {
            background: white;
            border: 2px solid var(--red-border);
            border-radius: 12px;
            padding: 1.5rem;
        }

        .sick-day-header {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            margin-bottom: 1rem;
            color: var(--red-text);
        }

        .sick-day-header svg {
            width: 24px;
            height: 24px;
        }

        .sick-day-header h3 {
            font-size: 1.1rem;
            font-weight: 700;
        }

        .sadmans-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(150px, 1fr));
            gap: 1rem;
        }

        .sadmans-item {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.75rem;
            background: var(--red-bg);
            border-radius: 8px;
            font-weight: 600;
            color: var(--red-text);
        }

        .sadmans-item span {
            font-size: 1.25rem;
        }

        /* Monitoring Box */
        .monitoring-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 1.5rem;
        }

        .monitoring-card {
            background: white;
            border-radius: 12px;
            box-shadow: var(--shadow-md);
            overflow: hidden;
        }

        .monitoring-card-header {
            padding: 1rem 1.5rem;
            display: flex;
            align-items: center;
            gap: 0.75rem;
        }

        .monitoring-card-header svg {
            width: 24px;
            height: 24px;
        }

        .monitoring-card-header h3 {
            font-size: 1rem;
            font-weight: 700;
        }

        .monitoring-card-header.b12 { background: var(--blue-bg); color: var(--blue-text); }
        .monitoring-card-header.hba1c { background: var(--green-bg); color: var(--green-text); }
        .monitoring-card-header.renal { background: var(--amber-bg, #FEF3C7); color: #92400E; }

        .monitoring-card-body {
            padding: 1.5rem;
        }

        /* Quick Reference Footer */
        .quick-ref-footer {
            background: var(--neutral-bg);
            border-top: 2px solid #E2E8F0;
            padding: 2rem;
            margin-top: 3rem;
        }

        .quick-ref-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .quick-ref-item {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 1rem;
            background: white;
            border-radius: 8px;
            box-shadow: var(--shadow-sm);
        }

        .quick-ref-item svg {
            width: 32px;
            height: 32px;
            flex-shrink: 0;
        }

        .quick-ref-item.green svg { color: var(--green-border); }
        .quick-ref-item.red svg { color: var(--red-border); }
        .quick-ref-item.blue svg { color: var(--blue-border); }

        .quick-ref-text strong {
            display: block;
            font-size: 0.85rem;
            color: var(--text-primary);
        }

        .quick-ref-text span {
            font-size: 0.8rem;
            color: var(--text-secondary);
        }

        /* Responsive */
        @media (max-width: 768px) {
            .nav-sidebar {
                display: none;
            }

            .main-content {
                margin-left: 0;
                padding: 1rem;
            }

            .drug-grid {
                grid-template-columns: 1fr;
            }

            .emergency-banner {
                flex-direction: column;
                text-align: center;
            }

            .drug-info-grid {
                grid-template-columns: 1fr;
            }
        }

        /* Print Styles */
        @media print {
            .nav-sidebar, .emergency-banner {
                display: none;
            }

            .main-content {
                margin-left: 0;
            }

            .drug-card:hover {
                transform: none;
                box-shadow: var(--shadow-md);
            }
        }
    </style>
</head>
<body>
    <!-- Emergency Banner -->
    <div class="emergency-banner">
        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"/>
        </svg>
        <div>
            <h1>RED FLAGS - ACT IMMEDIATELY</h1>
            <p>Symptomatic Hyperglycaemia → Consider rescue therapy (insulin or sulphonylurea)</p>
        </div>
    </div>

    <!-- Navigation Sidebar -->
    <nav class="nav-sidebar">
        <h3>Quick Navigation</h3>
        <a href="#red-flags" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"/>
            </svg>
            Red Flags & Emergency
        </a>
        <a href="#nice-guidance" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
            </svg>
            NICE 2022 Algorithm
        </a>
        <a href="#drug-cards" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"/>
            </svg>
            Drug Classes
        </a>
        <a href="#comparison" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 19v-6a2 2 0 00-2-2H5a2 2 0 00-2 2v6a2 2 0 002 2h2a2 2 0 002-2zm0 0V9a2 2 0 012-2h2a2 2 0 012 2v10m-6 0a2 2 0 002 2h2a2 2 0 002-2m0 0V5a2 2 0 012-2h2a2 2 0 012 2v14a2 2 0 01-2 2h-2a2 2 0 01-2-2z"/>
            </svg>
            Drug Comparison
        </a>
        <a href="#monitoring" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2m-6 9l2 2 4-4"/>
            </svg>
            Monitoring
        </a>
        <a href="#driving" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"/>
            </svg>
            DVLA Driving Rules
        </a>
        <a href="#sick-day" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
            </svg>
            Sick Day Rules
        </a>

        <h3 style="margin-top: 1.5rem;">Key Targets</h3>
        <a href="#targets" class="nav-link">
            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"/>
            </svg>
            HbA1c Targets
        </a>
    </nav>

    <!-- Main Content -->
    <main class="main-content">
        <!-- Section 1: Red Flags & Emergency -->
        <section id="red-flags" class="section">
            <div class="section-header">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"/>
                </svg>
                <h2>Red Flags - Emergency Actions Required</h2>
            </div>

            <div class="red-flag-grid">
                <div class="red-flag-card">
                    <h3>
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"/>
                        </svg>
                        Symptomatic Hyperglycaemia
                    </h3>
                    <ul>
                        <li>Polyuria, polydipsia, weight loss, fatigue</li>
                        <li>Blurred vision, slow wound healing</li>
                        <li>Recurrent infections (UTI, candidiasis)</li>
                        <li><strong>ACTION:</strong> Consider rescue therapy with insulin or sulphonylurea</li>
                        <li>Review and adjust regular therapy once controlled</li>
                    </ul>
                </div>

                <div class="red-flag-card">
                    <h3>
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M20.354 15.354A9 9 0 018.646 3.646 9.003 9.003 0 0012 21a9.003 9.003 0 008.354-5.646z"/>
                        </svg>
                        Severe Hypoglycaemia
                    </h3>
                    <ul>
                        <li>Requires assistance from another person</li>
                        <li>Impaired consciousness or seizure</li>
                        <li>Double long-term CVD risk (BMJ 2013)</li>
                        <li><strong>AVOID:</strong> Sulphonylureas in drivers, elderly, frail</li>
                        <li>Use CGM in high-risk patients</li>
                    </ul>
                </div>

                <div class="red-flag-card">
                    <h3>
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"/>
                        </svg>
                        DKA Risk with SGLT2i
                    </h3>
                    <ul>
                        <li>Euglycaemic DKA possible - low glucose but high ketones</li>
                        <li>Risk during acute illness, surgery, fasting</li>
                        <li>Symptoms: nausea, vomiting, abdominal pain</li>
                        <li><strong>ACTION:</strong> Stop SGLT2i during acute illness - see sick day rules</li>
                        <li>Measure ketones if suspected</li>
                    </ul>
                </div>

                <div class="red-flag-card">
                    <h3>
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4.318 6.318a4.5 4.5 0 000 6.364L12 20.364l7.682-7.682a4.5 4.5 0 00-6.364-6.364L12 7.636l-1.318-1.318a4.5 4.5 0 00-6.364 0z"/>
                        </svg>
                        Cardiovascular Emergency
                    </h3>
                    <ul>
                        <li>Offer gliflozin to ALL with established CVD</li>
                        <li>Consider gliflozin for those with CV risk factors</li>
                        <li>GLP-1s reserved for obesity per NICE</li>
                        <li>Benefits seen across all outcomes (mortality, HF, renal)</li>
                        <li>Early intensive control reduces lifetime complications</li>
                    </ul>
                </div>
            </div>
        </section>

        <!-- Section 2: NICE 2022 Algorithm -->
        <section id="nice-guidance" class="section">
            <div class="section-header">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                </svg>
                <h2>NICE 2022 Algorithm - First-Line Therapy</h2>
            </div>

            <div class="nice-box">
                <h3>
                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <path stroke" stroke-linejoin-linecap="round="round" stroke-width="2" d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2m-6 9l2 2 4-4"/>
                    </svg>
                    Major Change: Gliflozins Now First-Line (with Metformin)
                </h3>

                <div class="algorithm-step">
                    <span class="step-box metformin">Metformin</span>
                    <span class="arrow">+</span>
                    <span class="step-box gliflozin">Gliflozin (SGLT2i)</span>
                    <span class="arrow">→</span>
                    <span class="step-box decision">New First-Line for High CV Risk</span>
                </div>

                <div style="margin-top: 1.5rem; padding: 1rem; background: white; border-radius: 8px;">
                    <p style="font-size: 0.9rem; margin-bottom: 1rem;"><strong>Who should get gliflozin as first-line?</strong></p>
                    <ul style="list-style: none; font-size: 0.9rem;">
                        <li style="padding: 0.4rem 0; padding-left: 1.5rem; position: relative;">
                            <span style="position: absolute; left: 0; color: var(--green-border); font-weight: bold;">✓</span>
                            Established CVD (MI, stroke, PAD, HF) - <strong>OFFER</strong>
                        </li>
                        <li style="padding: 0.4rem 0; padding-left: 1.5rem; position: relative;">
                            <span style="position: absolute; left: 0; color: var(--green-border); font-weight: bold;">✓</span>
                            CV risk factors (QRISK >10%) - <strong>CONSIDER</strong>
                        </li>
                        <li style="padding: 0.4rem 0; padding-left: 1.5rem; position: relative;">
                            <span style="position: absolute; left: 0; color: var(--blue-border);">•</span>
                            Others may still benefit - use clinical judgment
                        </li>
                    </ul>
                </div>
            </div>

            <div class="two-column">
                <div class="nice-box" style="margin-bottom: 0;">
                    <h3 style="margin-bottom: 1rem;">
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"/>
                        </svg>
                        When to Intensify
                    </h3>
                    <ul style="list-style: none; font-size: 0.9rem;">
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(37, 99, 235, 0.2);">
                            <strong>HbA1c ≥ 58mmol/mol (7.5%)</strong> on dual therapy
                        </li>
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(37, 99, 235, 0.2);">
                            <strong>HbA1c ≥ 53mmol/mol (7%)</strong> on single drug
                        </li>
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(37, 99, 235, 0.2);">
                            <strong>Personalise targets</strong> - not everyone needs tight control
                        </li>
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(37, 99, 235, 0.2);">
                            <strong>De-intensify</strong> if HbA1c <48mmol/mol (6.5%)
                        </li>
                        <li style="padding: 0.5rem 0;">
                            <strong>Consider frailty</strong> - avoid hypos in elderly
                        </li>
                    </ul>
                </div>

                <div class="nice-box" style="margin-bottom: 0; background: linear-gradient(135deg, var(--green-bg), #DCFCE7); border-color: var(--green-border);">
                    <h3 style="color: var(--green-text); margin-bottom: 1rem;">
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                        </svg>
                        Key Benefits Evidence
                    </h3>
                    <ul style="list-style: none; font-size: 0.9rem; color: var(--green-text);">
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(22, 163, 74, 0.2);">
                            <strong>Gliflozins:</strong> 17 fewer deaths/1000 over 5 years
                        </li>
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(22, 163, 74, 0.2);">
                            <strong>GLP-1s:</strong> Same mortality benefit, weight loss
                        </li>
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(22, 163, 74, 0.2);">
                            <strong>Heart Failure:</strong> 33 fewer admissions/1000 (gliflozins)
                        </li>
                        <li style="padding: 0.5rem 0; border-bottom: 1px solid rgba(22, 163, 74, 0.2);">
                            <strong>Renal:</strong> 34 fewer ESKD/1000 over 5 years (gliflozins)
                        </li>
                        <li style="padding: 0.5rem 0;">
                            <strong>Meta-analysis BMJ 2023:</strong> 500,000 patients
                        </li>
                    </ul>
                </div>
            </div>
        </section>

        <!-- Section 3: Drug Cards -->
        <section id="drug-cards" class="section">
            <div class="section-header">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"/>
                </svg>
                <h2>Drug Classes - Quick Reference</h2>
            </div>

            <div class="drug-grid">
                <!-- Metformin -->
                <div class="drug-card">
                    <div class="drug-card-header blue">
                        <div>
                            <div class="drug-name">Metformin</div>
                            <div class="drug-examples">Glucophage, Glucophage SR</div>
                        </div>
                        <span class="drug-tag tag-first-line">First Line</span>
                    </div>
                    <div class="drug-card-body">
                        <div class="drug-info-grid">
                            <div class="info-box benefits">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Benefits
                                </h4>
                                <ul>
                                    <li>CV protection proven</li>
                                    <li>Low hypo risk</li>
                                    <li>Weight neutral/neutral</li>
                                    <li>Cheapest option</li>
                                    <li>Reduces hepatic glucose</li>
                                </ul>
                            </div>
                            <div class="info-box risks">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Cautions
                                </h4>
                                <ul>
                                    <li>GI side effects common</li>
                                    <li>Reduces B12 - check levels</li>
                                    <li>Stop if eGFR <30</li>
                                    <li>Caution with contrast</li>
                                    <li>Not in acute illness</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Gliflozins (SGLT2i) -->
                <div class="drug-card">
                    <div class="drug-card-header green">
                        <div>
                            <div class="drug-name">Gliflozins (SGLT2i)</div>
                            <div class="drug-examples">Dapagliflozin, Empagliflozin, Canagliflozin</div>
                        </div>
                        <span class="drug-tag tag-first-line">First Line</span>
                    </div>
                    <div class="drug-card-body">
                        <div class="drug-info-grid">
                            <div class="info-box benefits">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Benefits
                                </h4>
                                <ul>
                                    <li>Proven CV mortality benefit</li>
                                    <li>Reduces HF admissions</li>
                                    <li>Renal protection</li>
                                    <li>Weight loss (2-3kg)</li>
                                    <li>BP reduction (2mmHg)</li>
                                </ul>
                            </div>
                            <div class="info-box risks">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Risks
                                </h4>
                                <ul>
                                    <li>Genital infections (13%)</li>
                                    <li>Euglycaemic DKA risk</li>
                                    <li>Amputations (canagliflozin)</li>
                                    <li>Fournier's gangrene rare</li>
                                    <li>Sick day rules apply</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- GLP-1 Receptor Agonists -->
                <div class="drug-card">
                    <div class="drug-card-header green">
                        <div>
                            <div class="drug-name">GLP-1 Receptor Agonists</div>
                            <div class="drug-examples">Semaglutide, Liraglutide, Dulaglutide</div>
                        </div>
                        <span class="drug-tag tag-cv-benefit">CV Benefit</span>
                    </div>
                    <div class="drug-card-body">
                        <div class="drug-info-grid">
                            <div class="info-box benefits">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Benefits
                                </h4>
                                <ul>
                                    <li>CV mortality benefit</li>
                                    <li>Significant weight loss</li>
                                    <li>Best glycaemic control</li>
                                    <li>Reduces MACE</li>
                                    <li>COPD benefit shown</li>
                                </ul>
                            </div>
                            <div class="info-box risks">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Cautions
                                </h4>
                                <ul>
                                    <li>GI side effects (nausea)</li>
                                    <li>Injection required</li>
                                    <li>NICE: reserve for obesity</li>
                                    <li>Cost considerations</li>
                                    <li>Pancreatitis rare</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Sulphonylureas -->
                <div class="drug-card">
                    <div class="drug-card-header red">
                        <div>
                            <div class="drug-name">Sulphonylureas</div>
                            <div class="drug-examples">Gliclazide, Glipizide, Glimepiride</div>
                        </div>
                        <span class="drug-tag tag-hypo-risk">Hypo Risk</span>
                    </div>
                    <div class="drug-card-body">
                        <div class="drug-info-grid">
                            <div class="info-box benefits">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Benefits
                                </h4>
                                <ul>
                                    <li>Rapid glucose lowering</li>
                                    <li>Well established</li>
                                    <li>Low cost</li>
                                    <li>Once daily dosing</li>
                                    <li>Rescue therapy option</li>
                                </ul>
                            </div>
                            <div class="info-box risks">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Cautions
                                </h4>
                                <ul>
                                    <li>High hypo risk (109/1000)</li>
                                    <li>Weight gain</li>
                                    <li>Driving restrictions</li>
                                    <li>Elderly caution</li>
                                    <li>Pancreas-dependent</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Gliptins (DPP-4 Inhibitors) -->
                <div class="drug-card">
                    <div class="drug-card-header blue">
                        <div>
                            <div class="drug-name">Gliptins (DPP-4i)</div>
                            <div class="drug-examples">Sitagliptin, Linagliptin, Alogliptin</div>
                        </div>
                    </div>
                    <div class="drug-card-body">
                        <div class="drug-info-grid">
                            <div class="info-box benefits">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Benefits
                                </h4>
                                <ul>
                                    <li>Weight neutral</li>
                                    <li>Very low hypo risk</li>
                                    <li>Once daily oral</li>
                                    <li>Well tolerated</li>
                                    <li>Renal dose adjustments</li>
                                </ul>
                            </div>
                            <div class="info-box general">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 16h-1v-4h-1m1-4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    General
                                </h4>
                                <ul>
                                    <li>Weak glycaemic effect</li>
                                    <li>No CV outcome benefit</li>
                                    <li>May add to SU hypo risk</li>
                                    <li>Cholecystitis risk (+15/10000)</li>
                                    <li>Cheaper than GLP-1/SGLT2</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Insulin -->
                <div class="drug-card">
                    <div class="drug-card-header amber">
                        <div>
                            <div class="drug-name">Insulin</div>
                            <div class="drug-examples">Basal (Glargine, Detemir), Premixed, Rapid</div>
                        </div>
                        <span class="drug-tag tag-hypo-risk">Hypo Risk</span>
                    </div>
                    <div class="drug-card-body">
                        <div class="drug-info-grid">
                            <div class="info-box benefits">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Benefits
                                </h4>
                                <ul>
                                    <li>Most effective lowering</li>
                                    <li>Flexible regimens</li>
                                    <li>Rescue therapy</li>
                                    <li>Allows pregnancy</li>
                                    <li>Long-acting analogues safer</li>
                                </ul>
                            </div>
                            <div class="info-box risks">
                                <h4>
                                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                                    </svg>
                                    Cautions
                                </h4>
                                <ul>
                                    <li>Hypo risk (39/1000)</li>
                                    <li>Weight gain common</li>
                                    <li>Injection technique</li>
                                    <li>Driving restrictions</li>
                                    <li>Requires monitoring</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- Section 4: Drug Comparison Table -->
        <section id="comparison" class="section">
            <div class="section-header">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 19v-6a2 2 0 00-2-2H5a2 2 0 00-2 2v6a2 2 0 002 2h2a2 2 0 002-2zm0 0V9a2 2 0 012-2h2a2 2 0 012 2v10m-6 0a2 2 0 002 2h2a2 2 0 002-2m0 0V5a2 2 0 012-2h2a2 2 0 012 2v14a2 2 0 01-2 2h-2a2 2 0 01-2-2z"/>
                </svg>
                <h2>Drug Comparison - Evidence Summary (BMJ 2023, n=500,000)</h2>
            </div>

            <div class="table-container">
                <table class="comparison-table">
                    <thead>
                        <tr>
                            <th>Drug Class</th>
                            <th>HbA1c Reduction</th>
                            <th>All-Cause Mortality</th>
                            <th>CV Mortality</th>
                            <th>HF Admissions</th>
                            <th>Renal Outcomes</th>
                            <th>Hypo Risk</th>
                            <th>Weight</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Gliflozins (SGLT2i)</strong></td>
                            <td class="cell-highlight-green">-8 to -10 mmol/mol</td>
                            <td class="cell-highlight-green"><span class="check">✓</span> -17/1000 (5y)</td>
                            <td class="cell-highlight-green"><span class="check">✓</span> -14/1000</td>
                            <td class="cell-highlight-green"><span class="check">✓✓</span> -33/1000</td>
                            <td class="cell-highlight-green"><span class="check">✓✓</span> -34/1000</td>
                            <td><span class="neutral">Low</span></td>
                            <td class="cell-highlight-green"><span class="check">Loss</span></td>
                        </tr>
                        <tr>
                            <td><strong>GLP-1 Receptor Agonists</strong></td>
                            <td class="cell-highlight-green">-10 to -12 mmol/mol</td>
                            <td class="cell-highlight-green"><span class="check">✓</span> -17/1000 (5y)</td>
                            <td class="cell-highlight-green"><span class="check">✓</span> -13/1000</td>
                            <td class="cell-highlight-green"><span class="check">✓</span> -9/1000</td>
                            <td class="cell-highlight-green"><span class="check">✓</span> -14/1000</td>
                            <td><span class="neutral">Low</span></td>
                            <td class="cell-highlight-green"><span class="check">Loss</span></td>
                        </tr>
                        <tr>
                            <td><strong>Metformin</strong></td>
                            <td class="cell-highlight-green">-15 to -20 mmol/mol</td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">Low</span></td>
                            <td><span class="neutral">Neutral</span></td>
                        </tr>
                        <tr>
                            <td><strong>Sulphonylureas</strong></td>
                            <td class="cell-highlight-green">-10 to -12 mmol/mol</td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td class="cell-highlight-red"><span class="cross">✗</span> High (109/1000)</td>
                            <td class="cell-highlight-red"><span class="cross">✗</span> Gain</td>
                        </tr>
                        <tr>
                            <td><strong>Gliptins (DPP-4i)</strong></td>
                            <td>-6 to -8 mmol/mol</td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">Low</span></td>
                            <td><span class="neutral">Neutral</span></td>
                        </tr>
                        <tr>
                            <td><strong>Pioglitazone</strong></td>
                            <td class="cell-highlight-green">-8 to -10 mmol/mol</td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td class="cell-highlight-red"><span class="cross">✗</span> Harm (+48/1000)</td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">Low</span></td>
                            <td class="cell-highlight-red"><span class="cross">✗</span> Gain</td>
                        </tr>
                        <tr>
                            <td><strong>Basal Insulin</strong></td>
                            <td class="cell-highlight-green">-12 to -15 mmol/mol</td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td><span class="neutral">—</span></td>
                            <td class="cell-highlight-red"><span class="cross">✗</span> High (39/1000)</td>
                            <td class="cell-highlight-red"><span class="cross">✗</span> Gain</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>

        <!-- Section 5: Monitoring -->
        <section id="monitoring" class="section">
            <div class="section-header">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2m-6 9l2 2 4-4"/>
                </svg>
                <h2>Monitoring Requirements</h2>
            </div>

            <div class="monitoring-grid">
                <div class="monitoring-card">
                    <div class="monitoring-card-header b12">
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"/>
                        </svg>
                        <h3>Metformin & B12 Monitoring</h3>
                    </div>
                    <div class="monitoring-card-body">
                        <div style="background: var(--red-bg); padding: 1rem; border-radius: 8px; margin-bottom: 1rem;">
                            <p style="color: var(--red-text); font-weight: 600; font-size: 0.9rem;">
                                ⚠️ Metformin reduces B12 - affects ~1 in 10 patients
                            </p>
                        </div>
                        <ul style="list-style: none; font-size: 0.9rem;">
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Check B12</strong> if symptomatic (fatigue, neuropathy, glossitis)
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Risk increases</strong> with dose and duration
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Add to annual diabetes bloods</strong> for pragmatic monitoring
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Higher risk:</strong> Vegans, elderly, IBD, PPI users
                            </li>
                            <li style="padding: 0.5rem 0;">
                                <strong>Continue metformin</strong> if B12 deficiency confirmed (treat deficiency)
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="monitoring-card">
                    <div class="monitoring-card-header hba1c">
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 19v-6a2 2 0 00-2-2H5a2 2 0 00-2 2v6a2 2 0 002 2h2a2 2 0 002-2zm0 0V9a2 2 0 012-2h2a2 2 0 012 2v10m-6 0a2 2 0 002 2h2a2 2 0 002-2m0 0V5a2 2 0 012-2h2a2 2 0 012 2v14a2 2 0 01-2 2h-2a2 2 0 01-2-2z"/>
                        </svg>
                        <h3>Blood Glucose Monitoring</h3>
                    </div>
                    <div class="monitoring-card-body">
                        <ul style="list-style: none; font-size: 0.9rem;">
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>NOT routine</strong> for type 2 diabetes on oral meds
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Offer if:</strong> On insulin, hypoglycaemia risk, driving
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Confirm suspected hypoglycaemia</strong>
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Starting steroids</strong> - short term monitoring
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Pregnancy planning</strong> or pregnant
                            </li>
                            <li style="padding: 0.5rem 0;">
                                <strong>CGM</strong> for type 2 on multiple daily insulin with recurrent hypos
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="monitoring-card">
                    <div class="monitoring-card-header" style="background: #FEF3C7; color: #92400E;">
                        <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4.318 6.318a4.5 4.5 0 000 6.364L12 20.364l7.682-7.682a4.5 4.5 0 00-6.364-6.364L12 7.636l-1.318-1.318a4.5 4.5 0 00-6.364 0z"/>
                        </svg>
                        <h3>Renal Function & Dosing</h3>
                    </div>
                    <div class="monitoring-card-body">
                        <ul style="list-style: none; font-size: 0.9rem;">
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Check eGFR</strong> before starting, then annually
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Metformin:</strong> Stop if eGFR <30; halve dose if 30-45
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>SGLT2i:</strong> Can use down to eGFR 20 (dapagliflozin HF)
                            </li>
                            <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                <strong>Gliptins:</strong> Dose adjustment needed (except linagliptin)
                            </li>
                            <li style="padding: 0.5rem 0;">
                                <strong>Audit:</strong> Review dosing for all eGFR <45
                            </li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- HbA1c Targets Accordion -->
            <div id="targets" class="accordion" style="margin-top: 1.5rem;">
                <div class="accordion-item">
                    <div class="accordion-header">
                        <h4>
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"/>
                            </svg>
                            HbA1c Targets by Guideline
                        </h4>
                        <svg class="accordion-icon" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"/>
                        </svg>
                    </div>
                    <div class="accordion-content">
                        <div class="accordion-content-inner">
                            <div class="table-container" style="box-shadow: none;">
                                <table class="comparison-table" style="font-size: 0.85rem;">
                                    <thead>
                                        <tr>
                                            <th>Guideline</th>
                                            <th>Target (Non-Hypo Risk)</th>
                                            <th>Target (On SU/Insulin)</th>
                                            <th>De-intensify</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>NICE 2022</strong></td>
                                            <td>48 mmol/mol (6.5%)</td>
                                            <td>53 mmol/mol (7%)</td>
                                            <td>If <48 mmol/mol</td>
                                        </tr>
                                        <tr>
                                            <td><strong>SIGN 2017</strong></td>
                                            <td>53 mmol/mol (7%)</td>
                                            <td>53 mmol/mol (7%)</td>
                                            <td>If frail/elderly</td>
                                        </tr>
                                        <tr>
                                            <td><strong>ACP 2018</strong></td>
                                            <td colspan="2">53-64 mmol/mol (7-8%)</td>
                                            <td>If <53 mmol/mol</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <p style="margin-top: 1rem; font-size: 0.85rem; color: var(--text-secondary);">
                                <strong>Note:</strong> All guidelines emphasise individualisation. Target 53-63 mmol/mol for most adults ( BMJ 2019). Avoid intensive control in elderly, frail, or those with history of hypoglycaemia.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- Section 6: DVLA Driving Regulations -->
        <section id="driving" class="section">
            <div class="section-header">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"/>
                </svg>
                <h2>DVLA Driving Regulations (Updated December 2024)</h2>
            </div>

            <div class="dvla-grid">
                <div class="dvla-card">
                    <div class="dvla-card-header group1">
                        Group 1 (Ordinary Cars)
                    </div>
                    <div class="dvla-card-body">
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>DVLA notification NOT required for tablet-treated T2D</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>Flash/CGM monitors ALLOWED</span>
                        </div>
                        <div class="dvla-item red">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"/>
                            </svg>
                            <span>≤1 severe hypo in 12 months</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>Check BM ≤2h before driving</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>2-hourly checks on long journeys</span>
                        </div>
                        <div class="dvla-item red">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"/>
                            </svg>
                            <span>If BM ≤4mmol/L - don't drive</span>
                        </div>
                    </div>
                </div>

                <div class="dvla-card">
                    <div class="dvla-card-header group2">
                        Group 2 (PSV/LGV)
                    </div>
                    <div class="dvla-card-body">
                        <div class="dvla-item red">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"/>
                            </svg>
                            <span>NO severe hypos in 12 months</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>Full hypo awareness required</span>
                        </div>
                        <div class="dvla-item red">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"/>
                            </svg>
                            <span>Flash/CGM NOT allowed - finger pricks only</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>BM meter with 3-month memory</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>Minimum twice daily testing when not driving</span>
                        </div>
                        <div class="dvla-item red">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"/>
                            </svg>
                            <span>SU/Insulin treated - high scrutiny</span>
                        </div>
                    </div>
                </div>

                <div class="dvla-card">
                    <div class="dvla-card-header sulphonylurea">
                        Sulphonylurea-Specific
                    </div>
                    <div class="dvla-card-body">
                        <div class="dvla-item red">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"/>
                            </svg>
                            <span>Higher hypo risk - counsel carefully</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>Non-SU drugs preferred for drivers</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>Document hypo education</span>
                        </div>
                        <div class="dvla-item green">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"/>
                            </svg>
                            <span>Provide written advice</span>
                        </div>
                        <div class="dvla-item red">
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"/>
                            </svg>
                            <span>Never if impaired awareness</span>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- Section 7: Sick Day Rules -->
        <section id="sick-day" class="section">
            <div class="section-header">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                </svg>
                <h2>Sick Day Rules - SGLT2i (Gliflozin) Patients</h2>
            </div>

            <div class="sick-day-box">
                <div class="sick-day-header">
                    <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"/>
                    </svg>
                    <h3>CRITICAL: Stop SGLT2i During Acute Illness</h3>
                </div>

                <p style="margin-bottom: 1.5rem; font-size: 0.9rem;">
                    <strong>Why?</strong> Risk of euglycaemic DKA - glucose may be normal but ketones high. Patients may not recognise classic DKA symptoms.
                </p>

                <h4 style="margin-bottom: 1rem; color: var(--red-text);">SADMANS Mnemonic - Drugs to Pause:</h4>
                <div class="sadmans-grid">
                    <div class="sadmans-item">
                        <span>S</span> SGLT2 inhibitors
                    </div>
                    <div class="sadmans-item">
                        <span>A</span> ACE inhibitors
                    </div>
                    <div class="sadmans-item">
                        <span>D</span> Diuretics
                    </div>
                    <div class="sadmans-item">
                        <span>M</span> Metformin
                    </div>
                    <div class="sadmans-item">
                        <span>A</span> ARBs
                    </div>
                    <div class="sadmans-item">
                        <span>N</span> NSAIDs
                    </div>
                    <div class="sadmans-item">
                        <span>S</span> Sulfonylureas
                    </div>
                </div>

                <div style="margin-top: 1.5rem; padding: 1rem; background: var(--neutral-bg); border-radius: 8px;">
                    <p style="font-size: 0.9rem; font-weight: 600; margin-bottom: 0.5rem;">Patient Advice:</p>
                    <ul style="font-size: 0.85rem; margin-left: 1.5rem;">
                        <li>Keep taking insulin (if applicable)</li>
                        <li>Stay hydrated with sugar-containing fluids</li>
                        <li>Check blood glucose more frequently</li>
                        <li>Seek medical help if: persistent vomiting, unable to eat, confusion, or DKA symptoms</li>
                        <li>Restart SGLT2i when eating normally and recovered (24-48h)</li>
                    </ul>
                </div>
            </div>

            <!-- Additional Clinical Tips Accordion -->
            <div class="accordion" style="margin-top: 1.5rem;">
                <div class="accordion-item">
                    <div class="accordion-header">
                        <h4>
                            <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2"/>
                            </svg>
                            Clinical Quick Tips & Audit Points
                        </h4>
                        <svg class="accordion-icon" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                            <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"/>
                        </svg>
                    </div>
                    <div class="accordion-content">
                        <div class="accordion-content-inner">
                            <div class="two-column" style="gap: 1.5rem;">
                                <div>
                                    <h4 style="color: var(--blue-text); margin-bottom: 1rem;">Clinical Audit Points</h4>
                                    <ul style="list-style: none; font-size: 0.9rem;">
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ How many on metformin have eGFR <30?
                                        </li>
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ How many have eGFR <45 with unreviewed dosing?
                                        </li>
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ Are SGLT2i offered to all with CVD?
                                        </li>
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ Do SGLT2i patients know sick day rules?
                                        </li>
                                        <li style="padding: 0.5rem 0;">
                                            ✓ Can you measure ketones in your practice?
                                        </li>
                                    </ul>
                                </div>
                                <div>
                                    <h4 style="color: var(--green-text); margin-bottom: 1rem;">Practice Points</h4>
                                    <ul style="list-style: none; font-size: 0.9rem;">
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ Early intensive control = lifelong benefit (UKPDS 24y follow-up)
                                        </li>
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ Severe hypo doubles CVD risk
                                        </li>
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ SGLT2i + GLP-1 dual therapy: additive benefits
                                        </li>
                                        <li style="padding: 0.5rem 0; border-bottom: 1px solid #E2E8F0;">
                                            ✓ GLP-1s reduce COPD exacerbations
                                        </li>
                                        <li style="padding: 0.5rem 0;">
                                            ✓ Ertugliflozin has weaker CV evidence
                                        </li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>
    </main>

    <!-- Quick Reference Footer -->
    <footer class="quick-ref-footer">
        <div class="quick-ref-grid">
            <div class="quick-ref-item green">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/>
                </svg>
                <div class="quick-ref-text">
                    <strong>First-Line</strong>
                    <span>Metformin + SGLT2i (if CV risk)</span>
                </div>
            </div>
            <div class="quick-ref-item green">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4.318 6.318a4.5 4.5 0 000 6.364L12 20.364l7.682-7.682a4.5 4.5 0 00-6.364-6.364L12 7.636l-1.318-1.318a4.5 4.5 0 00-6.364 0z"/>
                </svg>
                <div class="quick-ref-text">
                    <strong>CV Protection</strong>
                    <span>SGLT2i and GLP-1 proven</span>
                </div>
            </div>
            <div class="quick-ref-item red">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"/>
                </svg>
                <div class="quick-ref-text">
                    <strong>Hypo Risk</strong>
                    <span>SU (109/1000), Insulin (39/1000)</span>
                </div>
            </div>
            <div class="quick-ref-item blue">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2"/>
                </svg>
                <div class="quick-ref-text">
                    <strong>B12 Check</strong>
                    <span>Add to metformin annual review</span>
                </div>
            </div>
            <div class="quick-ref-item red">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4m0 4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"/>
                </svg>
                <div class="quick-ref-text">
                    <strong>Stop SGLT2i</strong>
                    <span>During acute illness (SADMANS)</span>
                </div>
            </div>
            <div class="quick-ref-item green">
                <svg fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"/>
                </svg>
                <div class="quick-ref-text">
                    <strong>Target HbA1c</strong>
                    <span>53-63 mmol/mol for most adults</span>
                </div>
            </div>
        </div>
    </footer>

    <script>
        // Smooth scrolling for navigation links
        document.querySelectorAll('.nav-link').forEach(link => {
            link.addEventListener('click', function(e) {
                e.preventDefault();
                const targetId = this.getAttribute('href');
                const targetElement = document.querySelector(targetId);
                if (targetElement) {
                    targetElement.scrollIntoView({
                        behavior: 'smooth',
                        block: 'start'
                    });
                }
            });
        });

        // Accordion functionality
        document.querySelectorAll('.accordion-header').forEach(header => {
            header.addEventListener('click', function() {
                const item = this.parentElement;
                const isActive = item.classList.contains('active');

                // Close all accordion items
                document.querySelectorAll('.accordion-item').forEach(i => {
                    i.classList.remove('active');
                });

                // Open clicked item if it wasn't active
                if (!isActive) {
                    item.classList.add('active');
                }
            });
        });

        // Highlight table rows on hover
        document.querySelectorAll('.comparison-table tbody tr').forEach(row => {
            row.addEventListener('mouseenter', function() {
                this.style.transform = 'scale(1.01)';
                this.style.transition = 'transform 0.2s ease';
            });
            row.addEventListener('mouseleave', function() {
                this.style.transform = 'scale(1)';
            });
        });

        // Drug card hover effects
        document.querySelectorAll('.drug-card').forEach(card => {
            card.addEventListener('mouseenter', function() {
                this.style.borderColor = 'var(--blue-border)';
            });
            card.addEventListener('mouseleave', function() {
                this.style.borderColor = 'transparent';
            });
        });

        // Active navigation highlighting
        const sections = document.querySelectorAll('.section');
        const navLinks = document.querySelectorAll('.nav-link');

        window.addEventListener('scroll', () => {
            let current = '';
            sections.forEach(section => {
                const sectionTop = section.offsetTop;
                const sectionHeight = section.clientHeight;
                if (scrollY >= sectionTop - 200) {
                    current = section.getAttribute('id');
                }
            });

            navLinks.forEach(link => {
                link.style.background = '';
                link.style.borderLeftColor = 'transparent';
                if (link.getAttribute('href') === `#${current}`) {
                    link.style.background = 'var(--neutral-bg)';
                    link.style.borderLeftColor = 'var(--blue-border)';
                }
            });
        });

        // Animate elements on scroll
        const observerOptions = {
            threshold: 0.1,
            rootMargin: '0px 0px -50px 0px'
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.style.opacity = '1';
                    entry.target.style.transform = 'translateY(0)';
                }
            });
        }, observerOptions);

        document.querySelectorAll('.section').forEach(section => {
            section.style.opacity = '0';
            section.style.transform = 'translateY(20px)';
            section.style.transition = 'opacity 0.5s ease, transform 0.5s ease';
            observer.observe(section);
        });

        // Print functionality
        window.printPage = function() {
            window.print();
        };
    </script>
</body>
</html>
